A New York woman went to her gynecologist for an exam in 2005, complaining of a lump in her left breast.
Three months later, the patient went back to the breast surgeon, who again recommended an excisional biopsy, which the woman again refused. She was seen again 3 months later with the same recommendation and result. One year after the initial examination by the surgeon, the woman returned to the surgeon, noting that the lump had grown. She then agreed to the excisional biopsy, and stage IV breast cancer was diagnosed. The disease had spread to her lymph nodes, pelvis, and sacrum.
The patient sued both doctors, claiming that the diagnosis should have been made in 2005. She alleged that the gynecologist should have made a more timely referral and that the breast surgeon did not make a timely diagnosis and should have recommended a less invasive procedure than excisional biopsy, which would have diagnosed the cancer at her first visit.
LEGAL PERSPECTIVE Although a patient can, of course, refuse recommended procedures and treatments and is often given options to choose from for a course of action for herself, it is imperative that caregivers document in the chart what the patient has been told about the options given, the risks and benefits of each treatment, and the risks and benefits specific to the option chosen. This is especially critical in the possible delay of diagnosis of cancer case, in which the patient refuses to undergo the recommended diagnostic procedure.
Many risk managers advise that when a patient refuses a recommended procedure, the chart should include documentation of the patient's understanding of the risks associated with her decision, which may be written by the patient herself or may include her signature on a formal document stating her decision. It is not specifically stated in the case here, but because a $1.75 million settlement was paid in a case in whi ch the physician recommended a procedure over the course of a year, and the patient refused to undergo that procedure and then sued the physician for the delay, one might think it problematic that the surgeon just opined that the patient had a fibroadenoma in the first place or that the documentation in the chart was lacking as to whether the patient understood that the biopsy of the lump was necessary to obtain a diagnosis.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More